Andrew S. Robertson, Nahid Latif, Imein Bousnina, et al. Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspective. Nature Reviews Drug Discovery. 2025. doi:10.1038/d41573-025-00038-6
Andrew S. Robertson, Nahid Latif, Imein Bousnina, et al. Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspective. Nature Reviews Drug Discovery. 2025;24(6):401-402. doi:10.1038/d41573-025-00038-6
Sabina Neziri, Ahmet Efe Köseoğlu, Gülsüm Deniz Köseoğlu, Buminhan Özgültekin, Nehir Özdemir Özgentürk. Animal models in neuroscience with alternative approaches: Evolutionary, biomedical, and ethical perspectives. Animal Models and Experimental Medicine. 2024;7(6):868-880. doi:10.1002/ame2.12487
Amy Hinterberger, Sara Bea. How do scientists model humanness? A qualitative study of human organoids in biomedical research. Social Science & Medicine. 2023;320:115676. doi:10.1016/j.socscimed.2023.115676
Dean G. Brown, Heike J. Wobst, Abhijeet Kapoor, Leslie A. Kenna, Noel Southall. Clinical development times for innovative drugs. Nature Reviews Drug Discovery. 2021;21(11):793-794. doi:10.1038/d41573-021-00190-9
Talia H. Swartz, Ann-Gel S. Palermo, Sandra K. Masur, Judith A. Aberg. The Science and Value of Diversity: Closing the Gaps in Our Understanding of Inclusion and Diversity. The Journal of Infectious Diseases. 2019;220(S2):S33-S41. doi:10.1093/infdis/jiz174